• AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more...

  • May 21 2024
  • Length: 10 mins
  • Podcast
AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more... By cover art

AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more...

Listen for free

View show details

  • Summary

  • (0:10): AstraZeneca to Invest $1.5B in Singapore for Revolutionary Cancer Drug Manufacturing Facility

    (1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection

    (3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End

    (5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery

    (8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation Theories

    To subscribe visit https://www.brief.news.
    For more updates in your inbox each morning visit www.brief.news.

    Image credit: Quartz
    Show more Show less
Politics & Government Science
Show more Show less

What listeners say about AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more...

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available